SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-041869
Filing Date
2021-02-12
Accepted
2021-02-12 17:12:06
Documents
1
Group Members
GUY LEVYSOLEUS CAPITAL GROUP, LLCSOLEUS CAPITAL MASTER FUND, L.P.SOLEUS CAPITAL, LLCSOLEUS PE GP I, LLCSOLEUS PRIVATE EQUITY GP I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d75300dsc13ga.htm SC 13G/A 158893
  Complete submission text file 0001193125-21-041869.txt   160837
Mailing Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund I, L.P. (Filed by) CIK: 0001752427 (see all company filings)

IRS No.: 824521410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91812 | Film No.: 21629433
SIC: 2834 Pharmaceutical Preparations